Deep-Tech Funding Cycle & Risk Appetite

The deep-tech funding cycle remained in a selective recovery rather than a broad-based boom. The 2021-era funding environment for frontier technologies — including quantum, advanced semiconductors, space, robotics, photonics, and other capital-intensive R&D businesses — had already reset materially in 2022-2023 as higher policy rates, tighter financial conditions, and weaker IPO markets compressed valuation multiples and lengthened fundraising timelines. By mid-2024, the macro backdrop was still defined by restrictive but potentially peaking rates, a gradual reopening of risk appetite for high-quality growth themes, and continued investor preference for companies with strategic relevance, government support, and clearer commercialization milestones.

For quantum and adjacent deep-tech categories, funding conditions were better than for many consumer or software niches on a strategic basis, but still difficult in absolute terms. Investors increasingly differentiated between platform science with long duration and uncertain revenue timing versus businesses linked to national security, AI infrastructure, sovereign technology resilience, or industrial productivity. That meant the market rewarded companies able to frame their proposition around enabling compute, secure communications, sensing, or semiconductor independence. The result was a bifurcated market: top-tier rounds for category leaders and firms with strong syndicates still got done, while earlier-stage or technically interesting but commercially distant companies faced down rounds, insider-led extensions, or delayed processes.

The rate backdrop remained central. In the US, the Federal Reserve had kept the policy rate at 5.25%-5.50% since July 2023, and as of 2024-06 inflation progress had improved but was uneven. That mattered because deep-tech assets are highly duration-sensitive: much of their value sits in long-dated expected cash flows, so higher discount rates and a higher cost of capital directly pressure valuations. At the same time, a stable or eventually easing rate outlook improved sentiment at the margin, especially for small-cap and pre-profit technology names. Public market performance in AI-linked semis and infrastructure also helped reopen the idea that enabling technologies could command premium valuations, though the spillover to quantum remained partial given longer commercialization timelines.

Another major support came from public-sector and strategic capital. Industrial policy in the US and Europe, defense budgets, export controls, supply-chain localization, and sovereign competition in computing and sensing all increased the strategic premium on deep tech. For quantum specifically, government grants, research partnerships, and procurement-related funding continued to matter disproportionately relative to mainstream venture financing. Corporate venture, defense-linked capital, and strategic partnerships with cloud, semiconductor, or industrial players became more important as traditional crossover investors remained cautious.

The near-term outlook is shaped by three forces. First, whether policy easing actually arrives and lowers discount-rate pressure. Second, whether private markets continue to reward only AI-near themes or broaden toward other frontier technologies. Third, whether exit markets improve: without IPO reopening and stronger M&A, venture investors remain disciplined on new deployment. Overall, as of 2024-06 the deep-tech funding cycle looked off the bottom but still selective, milestone-driven, and far from the exuberance of 2021. Some data points here may now be dated given my 2024-06 knowledge cutoff.